Mualliflar

  • Шагазатова Б.Х., Рахимбердиева З.А., Сайдуллаев А.Ш.

##semicolon##

сахарный диабет 2 типа, хроническая болезнь почек, цистатин C, ранняя диагностика, почечная дисфункция.

##submission.citations##

1. Åkesson, A., Öberg, C. M., Malmgren, L., Nilsson, C., Itoh, Y., Blirup-Jensen, S., Lindström, V., Abrahamson, M., Leion, F., Ólafsson, Í., Bjursten, H., Grubb, D., Herou, E., Dardashti, A., Sigurjonsson, J., Xhakollari, L., Laučytė-Cibulskienė, A., Pottel, H., Strevens, H., … Grubb, A. (2025). Identification of cystatin C as a new marker of glomerular filtration rate, and of shrunken pore syndrome – a new kidney disorder defining selective glomerular hypofiltration syndromes – calls for expansion of the international KDIGO guidelines. Scandinavian Journal of Clinical and Laboratory Investigation, 85(6), 409. https:// doi.org/10.1080/00365513.2025.2546320

2. Al-Hazmi, S. F., Gad, H., Alamoudi, A. A., Eldakhakhny, B., Binmahfooz, S., & Alhozali, A. (2020). Evaluation of early biomarkers of renal dysfunction in diabetic patients. Saudi Medical Journal, 41(7), 690. https://doi.org/10.15537/smj.2020.7.25 168

3. AL-Nasrawii, M. S., Jasim, B. S., & Hassan, S. H. (2020). A comparative assessment of serum creatinine and cystatin c as a significance of nephropathy in diabetic patients. Malaysian Journal of Public Health Medicine, 20(3), 189. https:// doi.org/10.37268/mjphm/vol.20/no.3/art.527

4. Alobaidi, S. (2025). Emerging Biomarkers and Advanced Diagnostics in Chronic Kidney Disease: Early Detection Through Multi-Omics and AI. Diagnostics, 15(10), 1225. https://doi.org/10.3390/ diagnostics15101225

5. Al-Saedy, A. A. K., Turki, K. M., & Nadaa, S. Z. (2017a). Effect of serum cystatin C in early diabetic nephropathy in type 2 Iraqi diabetic patients. Journal of Contemporary Medical Sciences, 3(10), 208. https://doi.org/10.22317/jcms.v3i10.152

6. Al-Saedy, A. A. K., Turki, K. M., & Nadaa, S. Z. (2017b). Effect of serum cystatin C in early diabetic nephropathy in type 2 Iraqi diabetic patients. Journal of Contemporary Medical Sciences, 3(10), 208. https://doi.org/10.22317/jcms.06201702

7. Buturović, B. A. –, & Čavaljuga, S. (2005). Cystatin C as a marker for detection of early renal failure in diabetes type 2 patients. Bosnian Journal of Basic Medical Sciences, 5(4), 68. https://doi.org /10.17305/bjbms.2005.3237

8. Duan, A., Huang, Z., Zhao, Z., Zhao, Q., Jin, Q., Yan, L., Zhang, Y., Li, X., Zhang, S., Hu, M., Gao, L., An, C., Luo, Q., & Liu, Z. (2023). The potential of cystatin C as a predictive biomarker in pulmonary hypertension. BMC Pulmonary Medicine, 23(1). https:// doi.org/10.1186/s12890-023-02595-1

9. Ferguson, T. W., Komenda, P., & Tangri, N. (2015). Cystatin C as a biomarker for estimating glomerular filtration rate. Current Opinion in Nephrology & Hypertension, 24(3), 295. https://doi.org/10.1097 /mnh.0000000000000115

10. Gupta, K., Nayyar, S. B., Sachdeva, J. K., & Kumar, P. (2017). Cystatin C in the early diagnosis of diabetic nephropathy and its correlation with albuminuria. International Journal of Advances in Medicine, 4(1), 56. https://doi.org/10.18203/2349-3933.ijam 20170020

11. Hassan, M. G., Aboelnaga, M. M., Al-Arman, M., & Hatata, E.-S. Z. (2021). Urinary cystatin C as a biomarker of early renal dysfunction in type 2 diabetic patients. Diabetes & Metabolic Syndrome Clinical Research & Reviews, 15(4), 102152. https:// doi.org/10.1016/j.dsx.2021.05.025

12. Inker, L. A., Schmid, C. H., Tighiouart, H., Eckfeldt, J. H., Feldman, H. I., Greene, T., Kusek, J. W., Manzi, J., Lente, F. V., Zhang, Y. L., Coresh, J., & Levey, A. S. (2012). Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin C. New England Journal of Medicine, 367(1), 20. https://doi.org/ 10.1056/nejmoa1114248

13. Ismael, A., Raoof, A., & Tahseen, Y. H. (2024). Assessing the accuracy of cystatin C for estimating glomerular filtration rate in patients with kidney disease. Asia-Pacific Journal of Molecular Biology and Biotechnology, 39. https://doi.org/10.35118 /apjmbb.2024.032.4.05

14. Jasem, A. H., Haddad, N., Yaseen, N. T., & Alrufaie, M. M. (2024). Association of TGF-β1 with cystatin-C in patients with diabetic nephropathy. Anaesthesia Pain & Intensive Care, 28(1), 151. https:// doi.org/10.35975/apic.v28i1.2399

15. Jeon, Y. K., Kim, M. R., Huh, J. E., Mok, J. Y., Song, S. H., Kim, S. S., Kim, B. H., Lee, S. H., Kim, Y. K., & Kim, I. J. (2011). Cystatin C as an Early Biomarker of Nephropathy in Patients with Type 2 Diabetes. Journal of Korean Medical Science, 26(2), 258. https://doi.org/10.3346/jkms.2011.26.2.258

16. Karimi, F., Moazamfard, M., Taghvaeefar, R., Sohrabipour, S., Dehghani, A., Azizi, R., & Dinarvand, N. (2024). Early Detection of Diabetic Nephropathy Based on Urinary and Serum Biomarkers: An Updated Systematic Review. PubMed, 13, 104. https:// doi.org/10.4103/abr.abr_461_23